Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Acetylcysteine and Methamphetamine

Research Papers that Mention the Interaction

The use of NAC , a potent antioxidant, reversed the neurotoxic effects of HIV and methamphetamine , suggesting a novel approach to ameliorate the effects of HIV- and methamphetamine-associated cognitive deficits.
Journal of Virology  •  2020  |  View Paper
N-acetylcysteine NAC ) has been found to reduce the craving for methamphetamine and other drugs, but its effect on methamphetamine use and other clinically related endpoints are uncertain.
Trials  •  2019  |  View Paper
N-acetylcysteine also has antioxidant properties that protect against methamphetamine-induced toxicity and it may therefore assist in the management of the neuropsychiatric and neurocognitive effects of methamphetamine.
Drug and alcohol review  •  2017  |  View Paper
N-Acetylcysteine , catalase, and l-NG-monomethyl arginine citrate inhibited the ROS/RNS fluorescence signal induced by methamphetamine , which suggests the formation of hydrogen peroxide and RNS.
Molecular Pharmacology  •  2012  |  View Paper
Systemic injection of METH produced a sustained increase in NAc temperature, which was reversed by the DA D1 receptor antagonist SCH 23390 or acupuncture at HT7.
Addiction biology  •  2019  |  View Paper
Interestingly, systemic administration of N-acetylcysteine (NAC), a drug that both upregulates GLT-1 and promotes glial-glutamate release, reduced cued methamphetamine seeking.
Neuroscience  •  2019  |  View Paper
Our observations suggest that maternal METH exposure induced differential expression patterns of neurodevelopment‐related genes in the HPC and NAc of male and female mice, which may underlie the different cognitive behavior phenotypes in both genders.
Neuropharmacology  •  2018  |  View Paper
These results suggest that NAC could prevent the behavioral changes (acute hyperlocomotion and development of behavioral sensitization) in rats and neurotoxicity in rat striatum after administration of MAP , and that NAC would be a useful drug for treatment of several symptoms associated with MAP abuse.
Brain Research  •  2004  |  View Paper
These results suggest that NAC could attenuate the reduction of DAT in the monkey striatum after repeated administration of MAP.
Annals of the New York Academy of Sciences  •  2004  |  View Paper
These results suggest that NAC could attenuate the reduction of DAT in the monkey striatum after repeated administration of MAP.
Neuropsychopharmacology  •  2004  |  View Paper
Show More